The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and effectiveness of the PROMUS Element™
Everolimus-Eluting Coronary Stent System for the treatment of patients with up to 2 de novo
atherosclerotic coronary artery lesions.
This clinical trial compares outcomes in patients treated with PROMUS Element to those in
patients treated with a different everolimus-eluting coronary stent. The lesions are of
average length in average-sized vessels ("workhorse"). A companion sub-trial evaluates
outcomes in smaller vessels (SV) and another sub-trial evaluates outcomes in longer lesions
(LL).